Calendar SpringWorks Therapeutics, Inc.

Equities

SWTX

US85205L1070

Market Closed - Nasdaq 21:00:00 19/04/2024 BST 5-day change 1st Jan Change
40.1 USD -5.58% Intraday chart for SpringWorks Therapeutics, Inc. -6.20% +9.86%

Chart calendar SpringWorks Therapeutics, Inc.

613c5c09d4fb41ff6aa9efc77908c788._xphsYy6YizymNjCxBv3IlO4kIqCT0gY4AVRe73LmcU.mXs0ybzqAWXLqof1_CmeWj6A9P71Ci9xpUwHNdWN9_e5TDnk2PQ1QZ_KlQ~72c5fa527fe0f49d5efe3dc0e83563ac

Upcoming events on SpringWorks Therapeutics, Inc.

02/05/2024 11:30 Q1 2024 Earnings Release
02/05/2024 13:30 Q1 2024 Earnings Call
16/05/2024 14:30 Annual General Meeting
30/07/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on SpringWorks Therapeutics, Inc.

12/03/2024 13:00 Barclays Global Healthcare Conference
04/03/2024 19:50 TD Cowen Health Care Conference
27/02/2024 11:30 Q4 2023 Earnings Release
08/02/2024 19:00 Guggenheim Healthcare Talks Biotechnology Conference
08/01/2024 15:30 JPMorgan Healthcare Conference
30/11/2023 13:45 Evercore ISI HealthCONx Conference
28/11/2023 13:00 OGSIVEO Approval Call
16/11/2023 13:30 ReNeu Phase IIb Trial Topline Results Call
02/11/2023 16:30 Connective Tissue Oncology Society Meeting - Poster No: P 188
02/11/2023 10:30 Q3 2023 Earnings Release
02/08/2023 11:30 Q2 2023 Earnings Release
12/06/2023 19:20 Goldman Sachs Global Healthcare Conference - Fireside Chat
03/06/2023 22:30 American Society of Clinical Oncology Conference - Abstract No: 11514
03/06/2023 19:15 American Society of Clinical Oncology Meeting - Abstract No: 11564
31/05/2023 18:00 TD Cowen Oncology Innovation Summit
24/05/2023 18:00 Annual General Meeting
09/05/2023 19:20 Bank of America Healthcare Conference
03/05/2023 11:30 Q1 2023 Earnings Release
17/04/2023 20:50 American Association for Cancer Research Meeting - Abstract Number #: CT033
17/04/2023 20:20 American Association for Cancer Research Meeting - Abstract No: CT031

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
35,0
21,0
66.67%
0,00
0,00
-
0,00
0,00
-
5,45
1,01
439.77%

86,9

EBITDA
Million USD
Released
Forecast
Spread
-59,0
-60,0
1.64%
-46,0
-78,6
41.54%
-173
-151
-14.43%
-280
-275
-1.8%
-341
-334
-2.28%

-342

EBIT
Million USD
Released
Forecast
Spread
-59,2
-59,2
-0.12%
-46,3
-59,4
22.01%
-173
-156
-11.27%
-281
-275
-1.95%
-343
-332
-3.41%

-337

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-58,3
-58,1
-0.28%
-45,6
-44,7
-2.01%
-174
-155
-12.54%
-277
-275
-1.02%
-325
-314
-3.56%

-312

Net income
Million USD
Released
Forecast
Spread
-50,6
-58,2
13.06%
-45,6
-44,9
-1.58%
-174
-154
-13.22%
-277
-276
-0.54%
-325
-314
-3.41%

-330

EPS
USD
Released
Forecast
Spread
-3,81
-2,33
-63.73%
-1,05
-1,36
23%
-3,59
-3,24
-10.8%
-5,21
-5,25
0.67%
-5,15
-4,92
-4.69%

-4,69

Announcement Date12/03/2025/02/2124/02/2228/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
5,45
0,90
502.99%

11,9


19,1


27,1


39,8


45,7

EBITDA
Million USD
Released
Forecast
Spread
-55,7
-42,0
-32.5%
-61,4
-57,0
-7.65%
-68,8
-64,0
-7.53%
-71,5
-73,0
2.02%
-78,2
-76,0
-2.89%
-77,4
-84,0
7.8%
-82,5
-79,0
-4.39%





















EBIT
Million USD
Released
Forecast
Spread
-55,8
-41,9
-33.18%
-61,5
-57,7
-6.58%
-69,0
-63,8
-8.24%
-71,7
-70,5
-1.71%
-78,5
-73,0
-7.45%
-77,7
-78,9
1.53%
-82,9
-80,0
-3.63%
-84,0
-86,1
2.49%
-98,5
-88,2
-11.68%

-89,8


-85,8


-78,5


-73,4




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-56,1
-41,4
-35.51%
-61,8
-57,0
-8.45%
-69,1
-63,3
-9.03%
-72,4
-70,6
-2.6%
-74,2
-72,9
-1.72%
-73,4
-77,7
5.49%
-77,9
-77,9
-0.09%
-79,4
-84,0
5.39%
-94,3
-83,3
-13.19%

-85,6


-84,2


-77,7


-70,0




Net income
Million USD
Released
Forecast
Spread
-56,1
-41,4
-35.51%
-61,8
-57,0
-8.45%
-69,1
-63,3
-9.03%
-72,4
-70,6
-2.6%
-74,2
-72,9
-1.82%
-73,4
-77,7
5.49%
-77,9
-77,9
-0.09%
-79,4
-84,0
5.39%
-94,3
-83,3
-13.19%

-85,6


-84,2


-77,7


-70,0




EPS
USD
Released
Forecast
Spread
-1,16
-0,88
-32.12%
-1,26
-1,05
-19.93%
-1,41
-1,26
-12.26%
-1,37
-1,32
-3.99%
-1,17
-1,22
4.24%
-1,18
-1,25
5.83%
-1,25
-1,26
0.89%
-1,27
-1,33
4.54%
-1,45
-1,24
-17.2%

-1,19


-1,17


-1,10


-1,05


-1,16

Announcement Date24/02/2205/05/2204/08/2203/11/2228/02/2303/05/2302/08/2302/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SWTX Stock
  4. Calendar SpringWorks Therapeutics, Inc.